ImmunityBio responds to FDA scrutiny over Anktiva promotional claims with new protocols - Fierce Pharma
Fierce Pharma reports on ImmunityBio responds to FDA scrutiny over Anktiva promotional claims with new protocols in Science & Health.
Take A Coffee NEWS Staff··2 min read
Fierce Pharma reported ImmunityBio responds to FDA scrutiny over Anktiva promotional claims with new protocols. Take A Coffee NEWS is tracking the story on the Science & Health desk for readers following medicine, public health, research, climate, space, and science policy.
Source
Why it matters
The story belongs in this desk because it may affect readers tracking medicine, public health, research, climate, space, and science policy.